- $1.01bn
- $608.91m
- 25
- 15
- 60
- 24
Annual balance sheet for 89bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 205 | 151 | 188 | 579 | 440 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 210 | 162 | 196 | 594 | 476 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.166 | 0.15 | 0.455 | 2.34 | 1.59 |
Other Long Term Assets | |||||
Total Assets | 211 | 162 | 197 | 596 | 479 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 8.11 | 19.5 | 24.6 | 29.6 | 36.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.11 | 36.5 | 45 | 60 | 77.9 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 203 | 126 | 152 | 536 | 401 |
Total Liabilities & Shareholders' Equity | 211 | 162 | 197 | 596 | 479 |
Total Common Shares Outstanding |